One of the most prominent applications of Erwinia chrysanthemi L-asparaginase is in the treatment of acute lymphoblastic leukemia (ALL). Cancer cells, particularly leukemia cells, require a high amount of asparagine for survival. By depleting asparagine, the enzyme starves the cancer cells, inhibiting their growth and leading to cell death. This therapeutic strategy underscores the enzyme's importance in medical catalysis.
